Initial analysis of TCGA datasets confirmed a significantly higher B7-H3 RNA expression in pancreatic cancer tissue compared to healthy tissue, and flow cytometric analyses confirmed B7-H3 expression on various pancreatic cancer cell lines, albeit to differing extents. The gene discussed is CD276; the disease is pancreatic neoplasm.